Paid Clinical Trials Baton Rouge

Discover 248 paid clinical trials in Baton Rouge, Louisiana. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter

Filter results

Results: 248

Quemliclustat & ChemotherapyStudy of Quemliclustat and Chemotherapy Versus Placebo and Chemotherapy in Patients With Metastatic Pancreatic Ductal Adenocarcinoma

Recruiting

PHASE3

Sponsor:

Arcus Biosciences, Inc.

Location:

Baton Rouge LA, Hattiesburg MS, Houston TX, Dallas TXshow 29 more

Code:

NCT06608927

Conditions

Metastatic Pancreatic Ductal Adenocarcinoma

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Quemliclustat

Placebo

Nab-paclitaxel

Gemcitabine

ObeldesivirStudy of Obeldesivir to Treat Children With Respiratory Syncytial Virus (RSV) Infection

Recruiting

PHASE2

Sponsor:

Gilead Sciences

Location:

Lafayette LA, Houston TX, Tomball TX, Richmond TXshow 30 more

Code:

NCT06784973

Conditions

RSV Infection

Eligibility Criteria

Sex: All

Age: 0 - 5

Healthy Volunteers: Not accepted

Interventions

Obeldesivir

Obeldesivir Placebo

Lifestyle InterventionLifestyle Intervention for Improving Insulin Resistance and Concern for Health

Recruiting

Sponsor:

Pennington Biomedical Research Center

Location:

Baton Rouge LA

Code:

NCT05649176

Conditions

Insulin Sensitivity

Apathy

Eligibility Criteria

Sex: All

Age: 50 - 70+

Healthy Volunteers: Not accepted

Interventions

Diet without soy

Diet with soy

Lymphedema TreatmentLymphedema Treatment for Blunt Facial Trauma

Recruiting

Sponsor:

Our Lady of the Lake Hospital

Location:

Baton Rouge LA

Code:

NCT02977182

Conditions

Post-traumatic Facial Edema

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Complete Decongestive Therapy (CDT)

Nivolumab, Ipilimumab, CabozantinibTesting the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors

Recruiting

PHASE2

Sponsor:

National Cancer Institute (NCI)

Location:

Baton Rouge LA, Kenner LA, Metairie LA, New Orleans LAshow 368 more

Code:

NCT03866382

Conditions

Bladder Adenocarcinoma

Bladder Clear Cell Adenocarcinoma

Bladder Mixed Adenocarcinoma

Bladder Neuroendocrine Carcinoma

Bladder Small Cell Neuroendocrine Carcinoma

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Biospecimen Collection

Bone Scan

Cabozantinib S-malate

Computed Tomography

Echocardiography Test

SelinexorSelinexor in Maintenance Therapy After Systemic Therapy for Participants With p53 Wild-Type, Advanced or Recurrent Endometrial Carcinoma

Recruiting

PHASE3

Sponsor:

Karyopharm Therapeutics Inc

Location:

Baton Rouge LA, New Orleans LA, Jackson MS, Shreveport LAshow 71 more

Code:

NCT05611931

Conditions

Endometrial Cancer

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Selinexor

Matching Placebo for selinexor

Sacituzumab Tirutecan & PembrolizumabA Study of Sacituzumab Tirumotecan (MK-2870) as a Single Agent and in Combination With Pembrolizumab (MK-3475) Versus Treatment of Physician's Choice in Participants With HR+/HER2- Unresectable Locally Advanced or Metastatic Breast Cancer (MK-2870-010)

Recruiting

PHASE3

Sponsor:

Merck Sharp & Dohme LLC

Location:

Baton Rouge LA, Tyler TX, Fort Worth TX, Thomasville GAshow 26 more

Code:

NCT06312176

Conditions

Breast Neoplasms

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Sacituzumab tirumotecan

Pembrolizumab

Paclitaxel

Nab-paclitaxel

Capecitabine

MILDMILD® Percutaneous Image-Guided Lumbar Decompression: A Medicare Claims Study

Recruiting

Sponsor:

Vertos Medical, Inc.

Location:

Baton Rouge LA, Hammond LA, Thibodaux LA, Lafayette LAshow 1096 more

Code:

NCT03072927

Conditions

Lumbar Spinal Stenosis

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

MILD

Interspinous Process Decompression

AngelMed GuardianAngelMed Guardian® System PMA Post Approval Study

Recruiting

Sponsor:

Angel Medical Systems

Location:

Hammond LA, Covington LA, Mandeville LA, Fort Worth TXshow 11 more

Code:

NCT05412927

Conditions

Acute Coronary Syndrome

Eligibility Criteria

Sex: All

Age: 21+

Healthy Volunteers: Not accepted

Interventions

PMA P150009 AngelMed Guardian® System

TulisokibartA Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)

Recruiting

PHASE3

Sponsor:

Merck Sharp & Dohme LLC

Location:

Zachary LA, Tyler TX, Dothan AL, Dallas TXshow 52 more

Code:

NCT06430801

Conditions

Crohn's Disease

Eligibility Criteria

Sex: All

Age: 16 - 70+

Healthy Volunteers: Not accepted

Interventions

IV Tulisokibart

SC Tulisokibart

IV Placebo

SC Placebo